Pathology Management Company launches four new over-the-counter diagnostic tests
This article was originally published in Clinica
A UK company, Pathology Management Company (PMC), is to launch four new home diagnostic tests onto the over-the-counter (OTC) market, including what it claims is the world's first total and HDL cholesterol home test.
You may also be interested in...
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake - but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.
Alvotech has struck a major deal with Yangtze River Pharmaceutical that will allow eight of the biosimilars developer’s products to be commercialized in China.